COSCIENS Biopharma Inc. (CSCIF)
OTCMKTS · Delayed Price · Currency is USD
2.125
+0.015 (0.71%)
At close: Dec 18, 2025
COSCIENS Biopharma Market Cap
COSCIENS Biopharma has a market cap or net worth of $6.61 million as of December 19, 2025. Its market cap has decreased by -43.22% in one year.
Market Cap
6.61M
Enterprise Value
184.54K
Revenue
9.05M
Ranking
n/a
PE Ratio
n/a
Stock Price
$2.13
Market Cap Chart
Since April 22, 1996, COSCIENS Biopharma's market cap has decreased from 10.88B to 6.61M, a decrease of -99.94%. That is a compound annual growth rate of -22.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 18, 2025 | 6.98M | 45.21% |
| Dec 31, 2024 | 4.81M | -49.10% |
| Dec 29, 2023 | 9.45M | -38.75% |
| Dec 30, 2022 | 15.43M | -64.65% |
| Dec 31, 2021 | 43.65M | 64.32% |
| Dec 31, 2020 | 26.56M | 44.53% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 764.81M |
| Glass House Brands | 731.06M |
| Elite Pharmaceuticals | 521.06M |
| Northwest Biotherapeutics | 387.57M |
| CytoDyn | 359.75M |
| Silence Therapeutics | 294.27M |
| Nika Pharmaceuticals | 291.10M |
| American Oncology Network | 198.84M |